Clenpiq FDA Approval History
Last updated by Judith Stewart, BPharm on March 2, 2021.
FDA Approved: Yes (First approved November 28, 2017)
Brand name: Clenpiq
Generic name: sodium picosulfate, magnesium oxide, and anhydrous citric acid
Dosage form: Oral Solution
Company: Ferring Pharmaceuticals Inc.
Treatment for: Bowel Preparation
Clenpiq (sodium picosulfate, magnesium oxide, and anhydrous citric acid) is a stimulant laxative and osmotic laxative combination indicated for cleansing of the colon as a preparation for colonoscopy.
Development timeline for Clenpiq
| Date | Article |
|---|---|
| Nov 29, 2017 | Approval FDA Approves Clenpiq (sodium picosulfate, magnesium oxide, and anhydrous citric acid) Oral Solution for Colonoscopy Prep |
See also
Clenpiq (sodium picosulfate, magnesium oxide, and anhydrous citric acid) Consumer information
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
